Skip to main content

Oestra® vs Low-Dose Vaginal Estrogen

Why Oestra® Is Different from Low-Dose Vaginal Estrogen

This is one of the most common areas of confusion - because both use the vaginal route, but they are designed for very different purposes.
​

If you're currently using a low-dose vaginal estrogen product and considering a transition to Oestra®, it's important to understand that these therapies are not equivalent, even though they are both administered vaginally.
​

For most women, we recommend a gradual 2-week transition period when switching from low-dose vaginal estrogen to Oestra®. Rather than stopping your current therapy immediately, continue using your existing vaginal estrogen while beginning Oestra® and allow the two therapies to overlap for approximately two weeks. After that transition period, you can discontinue your previous therapy and continue with Oestra® alone.
​

This gradual transition helps support stable hormone levels and may reduce symptoms that can occur when changing hormone therapies.
​

With consistency and patience, most women find that the switch to Oestra® is smooth and appreciate the broader hormone support it is designed to provide.
​

If you ever feel unsure during your transition, our team is here to support you every step of the way.
​


Low-Dose Vaginal Estrogen

Products like:
​

  • Vaginal tablets

  • Low-dose creams

  • Local rings

Are designed to:
​

  • Treat vaginal dryness only

  • Deliver minimal systemic absorption

That’s why many studies describe them as “not systemic.”
​


Oestra® Is Different by Design

Oestra® uses:
​

  • Therapeutic (whole-body) dosing

  • A formulation designed for systemic absorption


The biggest difference between these treatments is their intended purpose. Low-dose vaginal estrogen products are generally designed to provide localized support for vaginal and urinary symptoms with minimal whole-body effects.
​
Oestra®, by contrast, is designed to provide broader hormone support throughout the body while also supporting vaginal and urinary health.
​

The vaginal route is capable of systemic delivery - it depends on the dose and formulation, not the route itself
​


Why Oestra® Works Systemically

  • The vaginal wall is highly vascular

  • Hormones enter the bloodstream directly

  • Blood levels increase in a dose-dependent way


What This Means for You

Oestra® can support:
​

  • Brain and mood

  • Bone health

  • Skin and metabolism

  • Vaginal and uterine tissue

Whereas low-dose products only target local symptoms.
​


Bottom Line

Low-dose vaginal estrogen is local therapy.
Oestra® is full-body hormone therapy using the same route—but at a therapeutic level.
​

Because Oestra® provides a different level of hormone support, some women notice an adjustment period as their bodies adapt during the transition.



​

Did this answer your question?